Touted to be among “the biggest breakthroughs in medicine in the last 10 years”, Sofosbuvir (brand name Sovaldi) was approved on December 6, 2013 by the U.S. Food and Drug Administration (FDA) as a new treatment...

Indian Patent Office recently published Patent (Amendment) Rules, 2014 and it includes few major updates that anyone applying for patents in India must be aware of. Following are the major ones that will really...

Google’s $3.2 billion acquisition of smart thermostat company, Nest Labs which also is its second biggest ever is certain to fortify company’s place in terms of intellectual property. Google had been weak on patents...

In 2006, the Indian patent office had rejected the patent application for Novartis cancer drug, “Glivec” on grounds that – –    The original molecule imatinib was in public domain before 1995—the cut-off year...

The Indian Patent Office (IPO) has issued new draft guidelines for pharmaceutical patents.  “Enhanced Therapeutic Efficacy” Replaces The Earlier Phrase “Enhanced Efficacy”: Becomes The Only Criteria For Grant Of A New Patent For Drug...